AzTrials
AzTrials

Fear of FallingAGESNCT07787819

Feasibility of Aktiv Gegen Sturzangst (AGES) in Assisted Living Facilities

A study testing Multicomponent fear of falling intervention in people with Fear of Falling, run by Eric Lenouvel at 3 sites in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aktiv Gegen Sturzangst (AGES) is a multicomponent group intervention combining cognitive behavioral therapy and structured exercise to address fear of falling in older adults receiving services from assisted living facilities. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Fear of Falling
What is being tested?
Multicomponent fear of falling intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
3 sitesSwitzerland
Study dates
1 Sep 2022to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age 65 years or older
  • Receiving some level of care or services through a participating assisted living facility
  • Identified by facility staff as potentially experiencing fear of falling or expressing interest in a fall-prevention program
  • Able to participate safely in group sessions

Who cannot join

  • Moderate to severe neurocognitive disorder
  • Unstable psychiatric illness, including an acute depressive episode or substance use disorder
  • Physical limitations precluding safe participation in group sessions, including blindness, severe frailty, wheelchair dependence, or requirement for full mobility assistance

Trial locations and contacts

3 sites in 1 country.

Switzerland3 sites
  • Domicil Spitalackerpark

    Bern, Canton of Bern, 3013

  • Alterswohnheim Büttenberg Biel

    Biel/Bienne, Canton of Bern, 2504

  • Senevita Résidence Beaulieu Murten

    Murten/Morat, Canton of Fribourg, 3280

Other trials in Switzerland

About this study

Official title: A Cognitive-Behavioral and Exercise Intervention to Reduce Fear of Falling in Older Adults in Assisted Living Facilities: A Pilot Study

Aktiv Gegen Sturzangst (AGES) is a multicomponent group intervention combining cognitive behavioral therapy and structured exercise to address fear of falling in older adults receiving services from assisted living facilities. This single-arm, non-randomized pilot study evaluated the feasibility of implementing AGES in three assisted living facilities in Switzerland and the feasibility of study procedures and outcome measures for a future controlled trial. Nineteen older adults participated in eight weekly group sessions delivered by trained course leaders. Feasibility outcomes included recruitment, retention, course-leader deployment, protocol adherence, completion of clinical outcome measures, and feasibility of contactless LiDAR-based gait assessment.

Read the detailed description

AGES was developed as an adaptation of multicomponent approaches to fear of falling for use in German-speaking Swiss assisted living facilities. The intervention consisted of eight weekly group sessions of approximately 60 minutes combining cognitive behavioral therapy-based discussion and reflection with structured balance, strength, mobility, and flexibility exercises. Sessions were delivered by trained facility-based course leaders. The pilot primarily assessed the feasibility of recruitment and retention, course-leader training and deployment, intervention delivery, completion of proposed outcome measures, and LiDAR-based gait assessment. Clinical measures included the Falls Efficacy Scale-International (FES-I), World Health Organization-5 Well-Being Index (WHO-5), and Timed Up and Go test (TUG). The study was exploratory and was not designed or powered to establish intervention effectiveness.

Conditions
Fear of Falling
Being tested
Multicomponent fear of falling intervention
Keywords
Older adults, Assisted living, Cognitive behavioral therapy, Exercise, Fall prevention, Mobility, Gait
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multicomponent fear of falling interventionBehavioural

    Also called Aktiv Gegen Sturzangst (AGES)

    Eight weekly group sessions delivered by trained course leaders. Sessions included cognitive behavioral therapy-based discussion and reflection addressing emotions, automatic thoughts, safety behaviors, assumptions, goal setting, and self-management, combined with structured exercises performed in seated or supported-standing positions where appropriate.

Study groups in NCT07787819
Study groupRoleWhat they receive
AGES InterventionExperimentalParticipants received the AGES intervention, consisting of eight weekly approximately 60-minute group sessions combining cognitive behavioral therapy-based components with structured physical exercises targeting balance, strength, mobility, and flexibility.
Receives: Behavioral: Multicomponent fear of falling intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Course-leader deployment

    Number and proportion of trained course leaders who subsequently delivered an AGES intervention group

    Measured: During the 8-week intervention period

  2. Participant retention

    Number and proportion of enrolled participants retained through completion of the intervention

    Measured: Baseline to approximately 8 weeks

  3. Completion of clinical outcome measures

    Number and proportion of participants providing paired FES-I, WHO-5 and TUG assessments

    Measured: Baseline and approximately 8 weeks

  4. Protocol adherence

    Number of delivering course leaders reporting delivery according to the standardized intervention manual without major deviations

    Measured: Through approximately 8 weeks

  5. Feasibility of LiDAR gait assessment

    Proportion of participants in whom LiDAR measurement could be acquired and proportion of acquired measurements yielding usable processed gait data

    Measured: At approximately Week 8, toward the end of the 8-week intervention period

Secondary outcomes (3)
  1. Falls Efficacy Scale-International (FES-I)

    The Falls Efficacy Scale-International (FES-I) is a 16-item questionnaire assessing concern about falling during physical and social activities. Each item is scored from 1 (not at all concerned) to 4 (very concerned), giving a total score ranging from 16 to 64. Higher scores indicate greater concern about falling and therefore a worse outcome.

    Measured: Baseline and approximately 8 weeks

  2. World Health Organization-5 Well-Being Index (WHO-5)

    The World Health Organization-5 Well-Being Index (WHO-5) is a 5-item questionnaire assessing subjective psychological well-being over the previous two weeks. Each item is scored from 0 (at no time) to 5 (all of the time), giving a total raw score ranging from 0 to 25. Higher scores indicate greater psychological well-being and therefore a better outcome.

    Measured: Baseline and approximately 8 weeks

  3. Timed Up and Go (TUG) Test

    The Timed Up and Go (TUG) test assesses functional mobility. Participants are timed, in seconds, while standing up from a chair, walking 3 meters, turning, walking back, and sitting down. The outcome is the time required to complete the test. Lower times indicate better functional mobility, whereas higher times indicate worse mobility.

    Measured: Baseline and approximately 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2026
  2. Study start1 Sep 2022
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Single-group, non-randomized pilot study in which all participants received the AGES intervention. No comparator or control group was included.
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07787819
Sponsor's protocol ID
AGES-2021
Other IDs
849 - Age-Stiftung Project ID
Acronym
AGES
Status last verified
Aug 2026
First submitted
19 Aug 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the results reported in the primary publication may be made available to qualified researchers upon reasonable request, subject to institutional approval, ethical and data-protection requirements, and assessment of the risk of participant re-identification.

Publications

  • Lenouvel E, Ullrich P, Siemens W, Dallmeier D, Denkinger M, Kienle G, Zijlstra GAR, Hauer K, Kloppel S. Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the community. Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014666. doi: 10.1002/14651858.CD014666.pub2.

    PubMed 37965937
  • Lenouvel E, Novak L, Biedermann A, Kressig RW, Kloppel S. Preventive treatment options for fear of falling within the Swiss healthcare system : A position paper. Z Gerontol Geriatr. 2022 Nov;55(7):597-602. doi: 10.1007/s00391-021-01957-w. Epub 2021 Sep 29.

    PubMed 34590162

Questions about this trial

What is this clinical trial studying?

A study testing Multicomponent fear of falling intervention in people with Fear of Falling, run by Eric Lenouvel at 3 sites in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Course-leader deployment (time frame: During the 8-week intervention period). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07787819, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in